PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Journal of Mid-life Health0 citationsOpen Access

Efficacy of Shankhapushpi (Convolvulus pluricaulis) in Posthysterectomy Menopausal Syndrome – A Randomized Controlled Pilot Clinical Trial

View Full Paper
DBDharthy BudihalKHKashavva V. HiremathOIOmkar D Ingale

Key Points

  • The study aims to evaluate the effects of Convolvulus pluricaulis on posthysterectomy menopausal syndrome.
  • Conducted a randomized controlled pilot trial with 30 women after hysterectomy.
  • Participants received either Shankhapushpi or Asparagus racemosus for 45 days.
  • Evaluated outcomes using menopause rating scale, modified Kupperman's index, and quality of life measures at multiple time points.
  • Both groups showed significant improvement in MRS, MKI, MS-QoL, and HARS scores (P < 0.001).
  • C. pluricaulis did not significantly increase serum estrogen levels compared to A. racemosus (P = 0.334).

Abstract

A BSTRACT Background: Menopause, cessation of woman’s reproduction otherwise can happen early by hysterectomy might need therapeutic attention, as it disturbs psychosomatic health by interruption in the hormonal physiology. Herbs rich in phytoestrogens like Convolvulus pluricaulis Choisy, known as Shankhapushpi in Ayurveda , are better nonhormonal alternatives to manage such conditions. Objective: The objective of the study was to evaluate the effect of C. pluricaulis in posthysterectomy menopausal syndrome. Materials and Methods: In this randomized controlled pilot trial, 30 women who underwent hysterectomy (before attaining natural menopause) meeting the inclusion criteria with a minimum menopause rating scale (MRS) score of 5 and a Modified Kupperman’s Index (MKI) score of 7, were randomized into two groups. 15 subjects of the control group received Asparagus racemosus Willd powder, and 15 subjects of the interventional group received C. pluricaulis powder, 6 g twice daily, respectively, after food with lukewarm water for a period of 45 days. Study outcome was evaluated through primary measures MRS, MKI, and Menopause-Specific Quality of Life (MS-QoL) on baseline, 15 th , 30 th , and 45 th day, whereas Serum estrogen and secondary measure Hamilton Anxiety Rating Scale (HARS) on baseline and 45 th day. Statistical results were expressed through Independent and Dependent t -tests. Results: Study results revealed that both interventions were comparable and each produced significant improvement ( P < 0.001) in MRS, MKI, MS-QoL, and HARS. C. pluricaulis has shown nonsignificant results in improving the serum estrogen levels ( P = 0.334) compared to A. racemosus ( P < 0.001). Conclusions: C. pluricaulis was beneficial in managing posthysterectomy menopausal syndrome, assessed through MRS, MKI, MS-QoL, and HARS. It was also helpful in maintaining stable estrogen levels, suggesting its possible efficacy as a nonhormonal herbal medicine.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Budihal et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd3da79560c99a0a3143https://doi.org/10.4103/jmh.jmh_37_25
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study2025
  2. 2Clinical evaluation of the efficiency of combined phytotherapy in the postoperative period in patients with uterus cancer2024
  3. 3Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial2024 · 3 citations
  4. 4Efficacy and safety of Shatavari root extract in women with Polycystic Ovarian Syndrome: a randomized, double-blind, placebo-controlled trial2026 · 2 citations
  5. 5Effectiveness of Lakshadi Guggulu, Shatawari Churna &amp; Abhyanga with Lakshadi tail on Menopausal Syndrome - R.C.T.2024